Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CCL21-induced immune cell infiltration.

Abdelkader E Ashour1, Heth R Turnquist, Rakesh K Singh

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

International Immunopharmacology
|December 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

American journal of hematology·2026
Same author

Regulatory T cell attracting therapy accelerates skeletal muscle functional recovery following injury.

Scientific reports·2026
Same author

A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer.

Acta biomaterialia·2026
Same author

Early-life viral infection generates pathological tissue-resident memory cells that contribute to asthma-like disease.

JCI insight·2026
Same author

Matrix-bound nanovesicles as epigenetic modulators of myeloid cells.

Science advances·2026
Same author

Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases.

Journal of controlled release : official journal of the Controlled Release Society·2025

Subcutaneous injection of CCL21 chemokine attracts dendritic cells (DCs) and T cells to lymph nodes, promoting lymphoid-like structures. This finding guides the therapeutic timing of CCL21 with vaccines for enhanced immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Chemoattractant Signaling

Background:

  • Cellular immune responses initiate through antigen presentation by dendritic cells (DCs) to T cells.
  • Chemokines, like CCL21, regulate DC and T cell trafficking, crucial for initiating T cell responses in lymphoid organs.
  • Understanding CCL21's cellular kinetics is vital for optimizing its therapeutic applications.

Purpose of the Study:

  • To investigate the cellular infiltration kinetics in response to subcutaneous CCL21 injection.
  • To determine the impact of CCL21 on dendritic cell and T cell populations in draining lymph nodes.
  • To inform the optimal timing for using CCL21 in therapeutic strategies, particularly with vaccines.

Main Methods:

  • Mice were injected subcutaneously with CCL21.

Related Experiment Videos

  • DC and T cell infiltration into the local draining lymph node was analyzed.
  • Cellular populations and tissue structures at the injection site were examined at a 4-day time point.

    • Main Results:

    • CCL21 injection significantly increased the numbers of lymphoid and myeloid DCs in the local lymph node.
    • A significant increase in effector T lymphocytes was observed in the draining lymph node 4 days post-injection.
    • Small lymphoid-like structures formed in the subcutaneous injection areas by day 4.

    Conclusions:

    • Subcutaneous CCL21 administration effectively recruits DCs and T cells to the local lymph node.
    • The formation of lymphoid-like structures suggests a localized immune activation environment.
    • These findings provide critical data for optimizing the timing of CCL21 administration in vaccine-based immunotherapies.